Sun Pharma to delist Ranbaxy on completion of $4-bn merger

Sun Pharmaceutical on Wednesday said Ranbaxy will be delisted from the Indian bourses following the completion of their $4-billion merger. "Following the closure of this transaction, Ranbaxy will......

India's richest man devours Matunga food, loves Harry Potter

How well do you know Dilip Shanghvi, who has emerged as India's richest man on the basis of market cap? Sun Pharma’s Dilip Shanghvi on Wednesday toppled Reliance Industries chief Mukesh......

Benefit of Ranbaxy deal to accrue in few years: Sun Pharma

It will take a ‘few years’ for Sun Pharma to realise the benefits of its $4 billion takeover of Ranbaxy, said the company's Chairman Israel Makov, terming the deal as a ‘complex......

'Premature to talk of changes in Ranbaxy top brass now'

Sun Pharmaceutical Industries will take a call on whether to shut Ranbaxy's troubled factories or make changes in the top management of the latter only after its $4-billion acquisition deal is......